Simplify Logo
GE Healthcare

GE Healthcare

Imaging, monitoring, and healthcare IT solutions

Content and Engagement Creation and Implementation Coordinator

Full-TimePosted on 7/27/2026Deadline 9/27/26
No salary listed
Entry, Junior, Mid
Bachelor's
Waukesha, WI, USA
Hybrid

At least three days per week in the office; relocation assistance is not provided.

No H1B Sponsorship

About the job

Requirements
  • A bachelor’s degree in marketing or a closely related field is required.
  • Demonstrated capability using digital tools such as artificial intelligence platforms, Adobe Suite, or comparable tools.
  • Familiarity with productivity tools such as Microsoft Teams, Box, and Microsoft Suite.
  • Currently living in or moving to the Milwaukee, Wisconsin area.
Responsibilities
  • Support the creation of final assets for comprehensive toolkits and creatively optimize assets for campaign enhancement.
  • Manage the catalog of existing assets, including editing, reviewing, and renewing legacy assets; catalog and organize newly created assets; and source and supply cataloged assets as requested.
  • Build, track, and manage repositories and systems so internal teams can access and use assets effectively.
  • Drive project management activities, including organization, timelines, purchase orders, invoicing, and budget activities, to support the timely and on-budget delivery of projects and ensure proper tracking and reporting.
  • Engage daily with Creation and Implementation Managers and assume additional responsibilities aligned with Strategy Managers as assigned.
  • Interact with Product and Regional Marketing teams to support campaign enablement and management.
Desired Qualifications
  • At least one year of experience in marketing or communications.
  • Experience in healthcare or another regulated business-to-business industry.
  • Creative design experience or education.

About the company

GE Healthcare Systems provides medical technologies and digital infrastructure to improve diagnosis, treatment, and monitoring of patients. Its products include imaging systems, mobile diagnostic devices, patient monitoring tools, and healthcare IT software that work together as hardware, software, and services to support hospitals, clinics, and researchers. The company differentiates itself with a large, integrated ecosystem, strong focus on AI analytics, and a global service network backed by substantial R&D investment. Its goal is to improve patient outcomes and the efficiency of healthcare delivery by enabling accurate diagnoses, effective treatments, and scaled operations.

Company Size

1-10

Company Stage

IPO

Headquarters

Chicago, Illinois

Founded

1892

Get referred to GE Healthcare

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 orders rose 11.1% and backlog hit a record $23.9 billion.
  • September 2026 brought FDA MRI clearances and CE marks for Photonova Spectra.
  • CareIntellect for Operations launched with Duke and Queen's Health to predict bottlenecks 72 hours ahead.

What critics are saying

  • Patient Care Solutions revenue fell 13.5% in Q2 2026; management still reviews a sale.
  • FDA classified an AW Server recall on June 24, 2026; wrong-patient reads threaten trust.
  • Aurora plant union filed NLRB charges in 2026, while shareholder fraud probes expanded September 2026.

What makes GE Healthcare unique

  • GE HealthCare spans MRI, CT, ultrasound, and radiopharmaceutical imaging across hospitals and clinics.
  • Photonova Spectra and SIGNA clearances show deep FDA-regulated imaging engineering and software integration.
  • CareIntellect, MIM Anyware, and AI-assisted ultrasound deepen workflow lock-in across clinical teams.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Tuition Reimbursement

Relocation Assistance

Company News

Yahoo Finance
Sep 15th, 2026
GE HealthCare launches AI tool to forecast hospital capacity bottlenecks 72 hours ahead

GE HealthCare has launched CareIntellect for Operations, an AI-powered software application that helps health systems forecast capacity constraints up to 72 hours ahead. The solution analyses hundreds of patient and operational data points to predict bottlenecks and recommend actions to optimise capacity and throughput. The Queen's Health Systems and Duke Health will be the first to implement the application. It uses two proprietary AI models: the Pressure Forecast model, which predicts resource constraints across hospitals and departments, and the Estimated Day of Discharge model, which predicts when patients will be discharged. The tool addresses operational challenges as US inpatient volumes rose 5.3% in 2025, requiring health systems to manage increased demand whilst facing staffing shortages and rising costs.

Yahoo Finance
Sep 1st, 2026
GE HealthCare secures CE mark for Photonova Spectra photon-counting CT system

GE HealthCare has received CE mark approval for its Photonova Spectra photon-counting computed tomography system, enabling commercial sales in markets recognising CE marking. The clearance follows US Food and Drug Administration approval and Japanese regulatory clearance in March 2026. The system uses GE HealthCare's Deep Silicon detector technology to deliver ultra-high definition spectral and spatial imaging. It processes data volumes up to 50 times greater than conventional CT systems, utilising Nvidia's accelerated computing platform. Clinical collaborations are underway at UZ Brussel in Belgium and Rigshospitalet in Denmark to evaluate the system across cardiology, neurology, oncology and musculoskeletal imaging. The CE mark follows more than $5 billion in innovation investment by GE HealthCare.

Yahoo Finance
Aug 31st, 2026
Vertex Pharmaceuticals shows promise while GE HealthCare and Wells Fargo face challenges

Vertex Pharmaceuticals has emerged as a standout S&P 500 stock, according to StockStory's analysis. The company, which focuses on developing transformative medicines for serious diseases including cystic fibrosis and sickle cell disease, boasts a market capitalisation of $137.3 billion. Meanwhile, StockStory recommends avoiding two large-cap stocks. GE HealthCare, spun off from General Electric in 2023, faces concerns over stagnant organic revenue growth and declining operating margins. The medical equipment provider has a market cap of $32.4 billion. Wells Fargo also made the avoid list. The diversified financial services company, with a $262.2 billion market cap, has seen its net interest margin shrink by 33.6 basis points over two years, suggesting increased competition or declining loan profitability.

Associated Press
Aug 28th, 2026
GE HealthCare launches three new Vivid cardiovascular ultrasound systems for diverse care settings

GE HealthCare has introduced three new cardiovascular ultrasound systems to its Vivid portfolio: Vivid Explorer 1, Vivid Advanced 1, and Vivid Focus 1. The systems were unveiled at the European Society of Cardiology Congress 2026 in Munich, Germany. Each system targets different clinical settings whilst sharing a common technology foundation with the ultra-premium Vivid Pioneer. Vivid Explorer is designed for high-volume echo labs, Vivid Advanced for mid-size hospitals and cardiology practices, and Vivid Focus for everyday cardiac imaging. All three systems use cSound imaging technology and include AI-enabled automation tools to streamline echo workflows. The systems have received CE Mark approval but are awaiting US FDA 510(k) clearance and are not yet available for sale in the United States.

Yahoo Finance
Aug 3rd, 2026
GE HealthCare launches Invenia ABUS Prime and StreamVue for breast cancer screening

GE HealthCare has launched Invenia ABUS Prime and ABUS StreamVue, expanding its breast imaging portfolio with solutions for supplemental screening in women with dense breasts. The Invenia ABUS Prime system has been installed at BeSound in Los Angeles, marking one of the first US installations. ABUS StreamVue is a browser-based reading solution enabling remote exam review across imaging networks. The system received FDA 510(k) clearance and CE Marking. Studies show 40% of women have dense breasts, carrying four to six times higher breast cancer risk. Research indicates mammography may miss one-third of cancers in dense breasts. Invenia ABUS Prime features AI-enabled tools including Scan Quality Assessment and can increase scan speed by up to 40%. The AI Assistant has demonstrated a 33% reduction in reading time.

INACTIVE